FDA Approved: EZETIMIBE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for ezetimibe (ANDA 210859). This is a routine supplemental approval for a generic ezetimibe produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)